Basit öğe kaydını göster

dc.contributor.authorGhadiri, Nooshin
dc.contributor.authorJavidan, Moslem
dc.contributor.authorSheikhi, Shima
dc.contributor.authorTaştan, Özge
dc.contributor.authorParodi, Alessandro
dc.contributor.authorLiao, Ziwei
dc.contributor.authorTayybi Azar, Mehdi
dc.contributor.authorGanjalıkhani-Hakemi, Mazdak
dc.date.accessioned2024-02-20T12:49:03Z
dc.date.available2024-02-20T12:49:03Z
dc.date.issued2024en_US
dc.identifier.citationGhadiri, N., Javidan, M., Sheikhi, S., Taştan, Ö., Parodi, A., Liao, Z. ... Ganjalıkhani-Hakemi, M. (2024). Bioactive peptides: An alternative therapeutic approach for cancer management. Frontiers in Immunology, 15. https://dx.doi.org/10.3389/fimmu.2024.1310443en_US
dc.identifier.issn1664-3224
dc.identifier.urihttps://dx.doi.org/10.3389/fimmu.2024.1310443
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12292
dc.description.abstractCancer is still considered a lethal disease worldwide and the patients’ quality of life is affected by major side effects of the treatments including post-surgery complications, chemo-, and radiation therapy. Recently, new therapeutic approaches were considered globally for increasing conventional cancer therapy efficacy and decreasing the adverse effects. Bioactive peptides obtained from plant and animal sources have drawn increased attention because of their potential as complementary therapy. This review presents a contemporary examination of bioactive peptides derived from natural origins with demonstrated anticancer, ant invasion, and immunomodulation properties. For example, peptides derived from common beans, chickpeas, wheat germ, and mung beans exhibited antiproliferative and toxic effects on cancer cells, favoring cell cycle arrest and apoptosis. On the other hand, peptides from marine sources showed the potential for inhibiting tumor growth and metastasis. In this review we will discuss these data highlighting the potential befits of these approaches and the need of further investigations to fully characterize their potential in clinics.en_US
dc.description.sponsorship32000802 ; 202102020181 ; ZSYXM202203 ; 21-75-30020en_US
dc.language.isoengen_US
dc.publisherFrontiers Media SAen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectAnticanceren_US
dc.subjectBioactive Peptideen_US
dc.subjectCancer Therapyen_US
dc.subjectImmunomodulationen_US
dc.subjectCancer Immunotherapyen_US
dc.titleBioactive peptides: An alternative therapeutic approach for cancer managementen_US
dc.typereviewen_US
dc.relation.ispartofFrontiers in Immunologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Rektörlük, Rejeneratif ve Restoratif Tıp Araştırmaları Merkezi (REMER)en_US
dc.departmentİstanbul Medipol Üniversitesi, Rektörlük, Sağlık Bilim ve Teknolojileri Araştırma Enstitüsüen_US
dc.identifier.volume15en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.3389/fimmu.2024.1310443en_US
dc.institutionauthorGanjalıkhani-Hakemi, Mazdak
dc.identifier.wosqualityQ1en_US
dc.identifier.wos001156577200001en_US
dc.identifier.scopus2-s2.0-85184230166en_US
dc.identifier.pmid38327525en_US
dc.identifier.scopusqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess